Potential for the G2/M arrest assay to predict patient susceptibility to severe reactions following radiotherapy

Strahlentherapie und Onkologie

Volumn 183, Issue 2, 2007, Pages 99-106

  Perez, Alexandra ^a   Grabenbauer, Gerhard G ^a   Sprung, Carl N ^b,c   Sauer, Rolf ^a   Distel, Luitpold V R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Individual radiosensitivity; LCLs; Radiation induced G2 M arrest; T lymphocytes

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; ATAXIA TELANGIECTASIA; CANCER PATIENT; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CLONOGENESIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DAMAGE; HUMAN; HUMAN CELL; IMAGE CYTOMETRY; IN VITRO STUDY; IONIZING RADIATION; LYMPHOBLASTOID CELL; NIJMEGEN BREAKAGE SYNDROME; RADIATION INJURY; RADIOSENSITIVITY; T LYMPHOCYTE;

ADULT; AGED; BIOLOGICAL ASSAY; CELL CYCLE; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; RADIATION DOSAGE; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY;

EID: 33847063486     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1565-9     Document Type: Article

References (38)

1. Antoccia A, di Masi A, Maraschio P, et al. G2-phase radiation response in lymphoblastoid cell lines from Nijmegen breakage syndrome. Cell Prolif 2002;35:93-104.
2. Baierlein SA, Distel L, Sieber R, et al. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5,637 bladder carcinoma cells. Strahlenther Onkol 2006;182:467-72.
3. Beamish H, Lavin MF. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int J Radiat Biol 1994;65:175-84.
4. Becker-Catania SG, Chen G, Hwang MJ, et al. Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. Mol Genet Metab 2000;70:122-33.
5. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000;92:874-97.
6. Bocking A, Giroud F, Reith A. Consensus report of the ESACP Task Force on Standardization of Diagnostic DNA Image Cytometry. European Society for Analytical Cellular Pathology. Anal Cell Pathol 1995;8:67-74.
7. Burdak-Rothkamm S, Rube CE, Nguyen TP, et al. Radiosensitivity of tumor cell lines after pretreatment with the EGFR tyrosine kinase inhibitor ZD1839 (Iressa®). Strahlenther Onkol 2005;181:197-204.
8. Burnet NG, Johansen J, Turesson I, et al. Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation Therapy. Int J Cancer 1998;79:606-13.
9. Chun HH, Gatti RA. Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst) 2004;3:1187-96.
10. Chun HH, Sun X, Nahas SA, et al. Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression. Mol Genet Metab 2003;80:437-43.
11. Coughlin SS, Khoury MJ, Steinberg KK. BRCA1 and BRCA2 gene mutations and risk of breast cancer. Public health perspectives. Am J Prev Med 1999;16:91-8.
12. Gilad S, Chessa L, Khosravi R, et al. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet 1998;62:551-61.
13. Grote HJ, Nguyen HV, Leick AG, et al. Identification of progressive cervical epithelial cell abnormalities using DNA image cytometry. Cancer 2004;102:373-9.
14. Haroske G, Baak JP, Danielsen H, et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal Cell Pathol 2001;23:89-95.
15. Hoeller U, Borgmann K, Bonacker M, et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 2003;69:137-44.
16. Keller U, Grabenbauer G, Kuechler A, et al. Radiation sensitivity testing by FISH: how many metaphases have to be analysed? Int J Radiat Biol 2004;80:615-20.
17. Keller U, Grabenbauer G, Kuechler A, et al. Cytogenetic instability in young patients with multiple primary cancers. Cancer Genet Cytogenet 2005;157:25-32.
18. Keller U, Kuechler A, Liehr T, et al. Impact of various parameters in detecting chromosomal aberrations by FISH to describe radiosensitivity. Strahlenther Onkol 2004;180:289-96.
19. Kuechler A, Neubauer S, Grabenbauer GG, et al. Is 24-color FISH detection of in-vitro radiation-induced chromosomal aberrations suited to determine individual intrinsic radiosensitivity? Strahlenther Onkol 2002;178:209-15.
20. Lavin MF, Bennett I, Ramsay J, et al. Identification of a potentially radiosensitive subgroup among patients with breast cancer. J Natl Cancer Inst 1994;86:1627-34.
21. Lavin MF, Le Poidevin P, Bates P. Enhanced levels of radiation-induced G2 phase delay in ataxia telangiectasia heterozygotes. Cancer Genet Cytogenet 1992;60:183-7.
22. Madigan MP, Ziegler RG, Benichou J, et al. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst 1995;87:1681-5.
23. Mayer A, Hockel M, Vaupel P. Endogenous hypoxia markers in locally advanced cancers of the uterine cervix: reality or wishful thinking? Strahlenther Onkol 2006;182:501-10.
24. Miller DG, Tiwari R, Pathak S, et al. DNA repair and mutagen sensitivity in patients with triple primary cancers. Cancer Epidemiol Biomarkers Prev 1998;7:321-7.
25. Neubauer S, Arutyunyan R, Stumm M, et al. Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting. Radiat Res 2002;157:312-21.
26. Neubauer S, Dunst J, Gebhart E. The impact of complex chromosomal rearrangements on the detection of radiosensitivity in cancer patients. Radiother Oncol 1997;43:189-95.
27. Newman B, Mu H, Butler LM, et al. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 1998;279:915-21.
28. Ott OJ, Potter R, Hammer J, et al. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial. Strahlenther Onkol 2004;180:642-9.
29. Oya N, Zolzer F, Werner F, et al. Effects of serum starvation on radiosensitivity, proliferation and apoptosis in four human tumor cell lines with different p53 status. Strahlenther Onkol 2003;179:99-106.
30. Parshad R, Sanford KK. Radiation-induced chromatid breaks and deficient DNA repair in cancer predisposition. Crit Rev Oncol Hematol 2001;37:87-96.
31. Pierce AJ, Stark JM, Araujo FD, et al. Double-strand breaks and tumorigenesis. Trends Cell Biol 2001;11:S52-9.
32. Roberts SA, Spreadborough AR, Bulman B, et al. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet 1999;65:784-94.
33. Rothkamm K, Lobrich M. Misrepair of radiation-induced DNA double-strand breaks and its relevance for tumorigenesis and cancer treatment [Review]. Int J Oncol 2002;21:433-40.
34. Scott D. Chromosomal radiosensitivity and low penetrance predisposition to cancer. Cytogenet Genome Res 2004;104:365-70.
35. Stankeova S, Crompton NE, Blattmann H, et al. Apoptotic response of irradiated T-lymphocytes. An epidemiologic study in canine radiotherapy patients. Strahlenther Onkol 2003;179:779-86.
36. Stumm M, Neubauer S, Keindorff S, et al. High frequency of spontaneous translocations revealed by FISH in cells from patients with the cancer-prone syndromes ataxia telangiectasia and Nijmegen breakage syndrome. Cytogenet Cell Genet 2001;92:186-91.
37. Windschall A, Ott OJ, Sauer R, et al. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma. Strahlenther Onkol 2005;181:545-50.
38. Wistop A, Keller U, Sprung CN, et al. Individual radiosensitivity does not correlate with radiation-induced apoptosis in lymphoblastoid cell lines or CD3+ lymphocytes. Strahlenther Onkol 2005;181:326-35.